ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 680,74
0,24%
Dow Jones
39 112,16
-0,76%
DAX
18 311,54
0,82%
Brent Oil
84,79
0,72%
Bitcoin
61 424,90
-0,62%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cesca Therapeutics Inc (KOOL)

  7. Cesca Therapeutics Inc (KOOL) Actualités

KOOL

Cesca Therapeutics (KOOL)

Cesca Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KOOL
DateHeureSourceTitreSymboleSociété
31/10/201911h30PR Newswire (US)Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic FocusNASDAQ:KOOLCesca Therapeutics Inc
24/10/201914h30PR Newswire (US)Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:KOOLCesca Therapeutics Inc
22/10/201916h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
22/10/201912h30PR Newswire (US)Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...NASDAQ:KOOLCesca Therapeutics Inc
14/10/201914h30PR Newswire (US)Cesca Therapeutics To Present At The 2019 Bio Investor ForumNASDAQ:KOOLCesca Therapeutics Inc
02/10/201914h30PR Newswire (US)Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution FeeNASDAQ:KOOLCesca Therapeutics Inc
25/09/201916h25PR Newswire (US)ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing DevicesNASDAQ:KOOLCesca Therapeutics Inc
24/09/201920h35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KOOLCesca Therapeutics Inc
19/09/201900h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
12/09/201923h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KOOLCesca Therapeutics Inc
09/09/201914h30PR Newswire (US)Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® ProductsNASDAQ:KOOLCesca Therapeutics Inc
03/09/201914h30PR Newswire (US)Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KOOLCesca Therapeutics Inc
13/08/201922h05PR Newswire (US)Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
06/08/201914h30PR Newswire (US)Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...NASDAQ:KOOLCesca Therapeutics Inc
23/07/201914h30PR Newswire (US)America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II SystemNASDAQ:KOOLCesca Therapeutics Inc
11/07/201922h35Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:KOOLCesca Therapeutics Inc
26/06/201914h30PR Newswire (US)Cesca Therapeutics Regains Nasdaq Listing ComplianceNASDAQ:KOOLCesca Therapeutics Inc
25/06/201914h30PR Newswire (US)Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in IndiaNASDAQ:KOOLCesca Therapeutics Inc
18/06/201914h30PR Newswire (US)ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingNASDAQ:KOOLCesca Therapeutics Inc
05/06/201914h30PR Newswire (US)ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine SymposiumNASDAQ:KOOLCesca Therapeutics Inc
04/06/201918h00PR Newswire (US)Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common StockNASDAQ:KOOLCesca Therapeutics Inc
31/05/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KOOLCesca Therapeutics Inc
16/05/201912h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:KOOLCesca Therapeutics Inc
14/05/201922h05PR Newswire (US)Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
13/05/201921h35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KOOLCesca Therapeutics Inc
07/05/201914h30PR Newswire (US)Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May...NASDAQ:KOOLCesca Therapeutics Inc
30/04/201921h44Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KOOLCesca Therapeutics Inc
22/04/201912h03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:KOOLCesca Therapeutics Inc
17/04/201914h00PR Newswire (US)ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research MarketNASDAQ:KOOLCesca Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KOOL

Dernières Valeurs Consultées

LSE
MLI
Industrials Reit
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés